Sandoz Group AG (SWX:SDZ)
Switzerland · Delayed Price · Currency is CHF 65.76
-1.60 (-2.38%)
Jul 31, 2026, 5:30 PM CET
Sandoz Group AG Revenue
In the year 2025, Sandoz Group AG had annual revenue of $11.16B USD with 7.44% growth. Sandoz Group AG had revenue of $5.89B in the half year ending December 31, 2025, with 16.70% growth.
Revenue
$11.16B
Revenue Growth
+7.44%
P/S Ratio
3.22
Revenue / Employee
$499.06K
Employees
22,356
Market Cap
28.45B CHF
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.16B | 773.00M | 7.44% |
| Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
| Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
| Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
| Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
| Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.96B |
| Novartis AG | 45.81B |
| Alcon | 8.53B |
| Lonza Group AG | 6.87B |
| Galderma Group AG | 4.16B |
| Galenica AG | 4.15B |
| Sonova Holding AG | 3.61B |
| Straumann Holding AG | 2.61B |
Sandoz Group AG News
- 10 days ago - Generic drug sector seeks policy fixes after Trump tariff threat - Reuters
- 11 days ago - Generic drugmaker Sandoz to engage with US after Trump tariff threat - Reuters
- 4 weeks ago - FDA set to review Sandoz's generic GLP-1s - Reuters
- 2 months ago - Generic drugmaker Sandoz files anti-dumping complaint about Chinese antibiotics imports - Reuters
- 3 months ago - Sandoz CEO Says Size of Weight-Loss Generics Market Is Unknown - WSJ
- 3 months ago - Sandoz Group AG Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Sandoz Group AG Slides: Q1 2026 - Filings
- 3 months ago - Sandoz Group AG Earnings release: Q1 2026 - Filings